Bills · 2021-2022 Regular Session
Relating to: diabetes medication pilot project and granting rule-making authority. (FE)
Disease Drugs Insurance — Commissioner office of Pharmacy Physical therapy
- Introduced, stopped here
- Passes Assembly, not reached
- Passes Senate, not reached
- Governor signs, not reached
- Law, not reached
Unfamiliar terms? Glossary
What this bill does
Plain-language analysis by the nonpartisan Legislative Reference Bureau
This bill directs the Office of the Commissioner of Insurance to develop a pilot
project under which a pharmacy benefit manager and pharmaceutical manufacturer
are directed to create a value-based, sole-source arrangement to reduce the costs of
prescription diabetes medication. The bill allows OCI to promulgate rules to
implement the pilot project.
What it would cost
Fiscal estimates filed by state agencies, as official PDFs
Sponsors
Introduced by: Anderson (D) , Baldeh (D) , Cabrera (D) , Conley (D) , Considine (D) , Doyle (D) , Emerson (D) , Hebl (D) , Hesselbein (D) , Hong (D) , Milroy (D) , Neubauer (D) , Ohnstad (D) , Pope (D) , S. Rodriguez (D) , Shankland (D) , Shelton (D) , Snodgrass (D) , Spreitzer (D) , Stubbs (D) , Subeck (D) , Vining (D) , Vruwink (D)
Full history
- Sep 10, 2021 · Assembly
Introduced by Representatives Subeck, Vining, Anderson, Baldeh, Cabrera, Conley, Considine, Doyle, Emerson, Hebl, Hesselbein, Hong, Milroy, Neubauer, Ohnstad, Pope, S. Rodriguez, Shankland, Shelton, Snodgrass, Spreitzer, Stubbs and Vruwink; cosponsored by Senators Erpenbach, Johnson, Agard, Carpenter, Larson, Pfaff and Roys
- Sep 10, 2021 · Assembly
Read first time and referred to Committee on Health
- Sep 28, 2021 · Assembly
Fiscal estimate received
- Mar 15, 2022 · Assembly
Failed to pass pursuant to Senate Joint Resolution 1